EA202092640A1 - METHODS AND COMPOSITIONS FOR TREATMENT OF CHRONIC urticaria - Google Patents

METHODS AND COMPOSITIONS FOR TREATMENT OF CHRONIC urticaria

Info

Publication number
EA202092640A1
EA202092640A1 EA202092640A EA202092640A EA202092640A1 EA 202092640 A1 EA202092640 A1 EA 202092640A1 EA 202092640 A EA202092640 A EA 202092640A EA 202092640 A EA202092640 A EA 202092640A EA 202092640 A1 EA202092640 A1 EA 202092640A1
Authority
EA
Eurasian Patent Office
Prior art keywords
treatment
chronic urticaria
methods
compositions
antibodies
Prior art date
Application number
EA202092640A
Other languages
Russian (ru)
Inventor
Кристофер Роберт Беббингтон
Ненад Томасевич
Хенрик Расмуссен
Original Assignee
Аллакос Инк.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Аллакос Инк. filed Critical Аллакос Инк.
Priority claimed from PCT/US2019/030523 external-priority patent/WO2019213468A1/en
Publication of EA202092640A1 publication Critical patent/EA202092640A1/en

Links

Landscapes

  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

Изобретение относится к способам лечения хронической крапивницы. В частности, изобретение обеспечивает способы лечения хронической крапивницы путем введения антител, которые связываются с Siglec-8 человека, или композиций, содержащих указанные антитела. В изобретении также представлены промышленные изделия или наборы для лечения хронической крапивницы, содержащие антитела, которые связываются с Siglec-8 человека.The invention relates to methods for the treatment of chronic urticaria. In particular, the invention provides methods for treating chronic urticaria by administering antibodies that bind to human Siglec-8, or compositions containing said antibodies. The invention also provides articles of manufacture or kits for the treatment of chronic urticaria containing antibodies that bind to human Siglec-8.

EA202092640A 2019-02-15 2019-05-03 METHODS AND COMPOSITIONS FOR TREATMENT OF CHRONIC urticaria EA202092640A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201962806657P 2019-02-15 2019-02-15
PCT/US2019/030523 WO2019213468A1 (en) 2018-05-04 2019-05-03 Methods and compositions for treating chronic urticaria

Publications (1)

Publication Number Publication Date
EA202092640A1 true EA202092640A1 (en) 2021-04-08

Family

ID=75817414

Family Applications (1)

Application Number Title Priority Date Filing Date
EA202092640A EA202092640A1 (en) 2019-02-15 2019-05-03 METHODS AND COMPOSITIONS FOR TREATMENT OF CHRONIC urticaria

Country Status (1)

Country Link
EA (1) EA202092640A1 (en)

Similar Documents

Publication Publication Date Title
EA201792221A1 (en) ANTIBODIES AGAINST SORTILINE AND METHODS OF THEIR APPLICATION
EA201890145A1 (en) ANTIBODIES TO FACTOR XI AND METHODS OF THEIR APPLICATION
PH12020500671A1 (en) Antibodies specific for gucy2c and uses thereof
EA201890453A1 (en) ANTI-ANGPTL8 ANTIBODIES AND THEIR APPLICATION
EA201891268A1 (en) COMPOUNDS WHICH CAN BE USED AS KINASE INHIBITORS
EA201890321A1 (en) ANTIBODY MOLECULES THAT BIND CD45
EA201991720A1 (en) ANTIBODIES TO ALPHA-SINUCLEIN AND THEIR APPLICATIONS
EA201791270A1 (en) MODIFIED APRIL-BINDING ANTIBODIES
EA201691470A1 (en) PROTEINS CONNECTING CALLICREIN PLASMA, AND THEIR APPLICATION FOR THE TREATMENT OF HEREDITARY ANGIONEUROTIC DOMESTIC
EA201890320A1 (en) ANTIBODY MOLECULES THAT BIND CD79
EA201892225A1 (en) ANTIBODIES TO THE COMPLEX Bb FACTOR AND THEIR APPLICATION
MX2022002682A (en) Anti-cd73 antibodies.
EA202190807A1 (en) ANTIBODIES TO SYNUCLEINE
NZ754676A (en) Use of anti-sclerostin antibodies in the treatment of osteogenesis imperfecta
MX2019009498A (en) Fgf21 mimetic antibodies and uses thereof.
EA201891527A1 (en) COMPOSITIONS AND METHODS OF DETECTION AND TREATMENT OF CANCER ETHESIS
MX2023004869A (en) Antibodies against sars-cov-2 and uses thereof.
EA202191666A1 (en) ANTIBODIES TO IL-27 AND THEIR USE
EA201992626A1 (en) METHODS AND COMPOSITIONS FOR TREATMENT OF ALLERGIC EYE DISEASES
MX2022014995A (en) Methods of treating iga nephropathy with an april binding antibody.
MX2021006362A (en) Single domain antibodies against cll-1.
BR112016023011A2 (en) gastric cancer treatment
EA201891529A1 (en) COMPOSITIONS AND METHODS OF DETECTION AND TREATMENT OF OVARIAN CANCER
EA202090741A1 (en) CONJUGATES OF ANTIBODY TO TISSUE FACTOR AND DRUG AND THEIR APPLICATION IN TREATMENT OF CANCER
MX2020011377A (en) Methods and compositions for treating chronic urticaria.